Stablecoin issuers are now among the top 20 holders of US Treasury bills.
Stablecoin issuers are now among the top 20 holders of US Treasury bills.
mUSD supply on Aave V3 (Ethereum). Read-only on Sharpe — deposits, withdrawals, and borrows execute on app.aave.com. We surface parameters, rates, and risk so you can compare this reserve against Morpho vaults on the same asset cohort.
Plain-English summary of this vault — what it does, who runs it, where the yield comes from, and what could break it. Generated from the same deterministic inputs shown elsewhere on this page; the numbers are the source, this is just the explanation.
You deposit mUSD and it is lent out to borrowers at a variable rate. Your deposit earns 2.65% APY, calculated from the 4.38% borrowers pay, multiplied by the 76.3% utilization rate, minus the 20% reserve factor that goes to Aave's treasury. You can redeem your deposit at any time up to the $8.0k available liquidity in the reserve; beyond that you queue for repayments. mUSD cannot be used as collateral in this reserve—borrow-only.
Aave governance has not flagged any unusual restrictions; the reserve operates under standard Aave V3 rules.
Supply APY tracks borrow demand. At 76.3% utilization, the reserve sits in a mid-range demand zone where rates are neither compressed by excess supply nor spiking from scarcity. The 20% reserve factor means 80 cents of every dollar of borrower interest flows to suppliers.
The reserve carries a risk score of 15/100 and no elevated-severity risks are flagged. The material constraint is liquidity: $8.0k available against $33.7k supplied means redemptions beyond that threshold will wait for borrower repayments.
Good fit for allocators seeking modest yield on a low-risk stablecoin if they hold for steady repayment cycles and don't need instant redemption above $8k.
On Aave V3, a supplier can withdraw up to the reserve's available liquidity instantly. Above that, the withdrawal must wait for borrowers to repay or new suppliers to deposit. Markets at 95%+ utilization can keep large redemptions waiting for hours to days at current rates.
Reserve parameters are set by Aave governance (BGD Labs + Aave Chan Initiative + Risk Council). Listings, caps, IRM curves, and LLTVs change through on-chain votes.
This reserve isn't usable as collateral, so LTV / Liquidation LLTV / liquidation bonus don't apply. Borrowers can take it against other collateral; suppliers earn the variable rate driven by borrow demand.
On Aave V3, supply APY = borrow APY × utilization × (1 − reserve factor). There is no curator skim; the only intermediation cost is the reserve factor, which funds the Aave treasury. No emissions slice in v1 of this integration — the headline is fully sustainable.
Aave V3 reserves carry parameter risk (LTV/LLTV adequacy vs collateral volatility), liquidity risk (high utilization slows exit), and depeg risk on the underlying. Governance can pause / freeze / adjust caps in response to incidents. Sharpe's full risk decomposition for Aave reserves rolls in v1.1.
How the composite risk score breaks down. Every number traces to an explicit input — /methodology documents each factor's formula.
Per-collateral decomposition: Sharpe-style realized σ from 30 daily log returns, blended 50/50 with the asset-taxonomy tier fallback. Phase 2 will replace the tier slot with liquidity depth, mechanism classification, and holder concentration. Methodology in /methodology.
The honest version. Every structural failure mode this vault is exposed to, ranked by severity. If you want to know whether to invest, start here.
Aave V3 prices and liquidations route through Chainlink's aggregator feed for this asset. A stale, manipulated, or wrong-side update is the protocol's largest single-point-of-failure for this reserve. Chainlink has a strong track record but the failure mode is binary.
Aave V3 has been live since March 2022 with significant TVL and continuous third-party audits. Historical incidents have been contained but the protocol surface is large (Pool / aTokens / debtTokens / IRM / Oracle / UiHelpers). Treat as bounded but non-zero tail risk.